These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29122635)

  • 61. Proton Pump Inhibitors and Clostridium difficile Infection.
    Goyal H; Katner H
    Am J Gastroenterol; 2017 May; 112(5):805. PubMed ID: 28469228
    [No Abstract]   [Full Text] [Related]  

  • 62. Editorial: PPIs and recurrent C. difficile infection: no association?
    Leontiadis GI
    Am J Gastroenterol; 2013 Nov; 108(11):1802-3. PubMed ID: 24192949
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acid suppression and the risk of Clostridium difficile infection.
    Mezoff EA; Cohen MB
    J Pediatr; 2013 Sep; 163(3):627-30. PubMed ID: 23759424
    [No Abstract]   [Full Text] [Related]  

  • 65. Re: proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Abdallah J; Hassan T; Kyprianou A
    Am J Gastroenterol; 2014 Apr; 109(4):601-2. PubMed ID: 24698870
    [No Abstract]   [Full Text] [Related]  

  • 66. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
    Gabriel L; Beriot-Mathiot A
    J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk factors of the Clostridium difficile infection in patients with chronic kidney disease.
    Lis Ł; Jerzak P; Konieczny A; Sroka M; Noceń-Rychlewska B; Podgórski P; Witkiewicz W; Hruby Z
    Adv Clin Exp Med; 2018 Aug; 27(8):1081-1084. PubMed ID: 29905987
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hospital roommates and development of health care-onset Clostridium difficile infection.
    Echaiz JF; Veras L; Zervos M; Dubberke E; Johnson L
    Am J Infect Control; 2014 Oct; 42(10):1109-11. PubMed ID: 25278404
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clostridium difficile colitis in patients undergoing lumbar spine surgery.
    Skovrlj B; Guzman JZ; Silvestre J; Al Maaieh M; Qureshi SA
    Spine (Phila Pa 1976); 2014 Sep; 39(19):E1167-73. PubMed ID: 24979408
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.
    Grigoras CA; Zervou FN; Zacharioudakis IM; Siettos CI; Mylonakis E
    PLoS One; 2016; 11(6):e0156577. PubMed ID: 27258068
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk and Severity of Hospital-Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors.
    Lewis PO; Litchfield JM; Tharp JL; Garcia RM; Pourmorteza M; Reddy CM
    Pharmacotherapy; 2016 Sep; 36(9):986-93. PubMed ID: 27455386
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients.
    Al-Tureihi FI; Hassoun A; Wolf-Klein G; Isenberg H
    J Am Med Dir Assoc; 2005; 6(2):105-8. PubMed ID: 15871884
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pathway to Prevention of Nosocomial Clostridium difficile Infection.
    Goldstein EJ; Johnson S; Maziade PJ; McFarland LV; Trick W; Dresser L; Millette M; Mazloum H; Low DE
    Clin Infect Dis; 2015 May; 60 Suppl 2():S148-58. PubMed ID: 25922401
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clostridium difficile infection: a comprehensive review.
    Kachrimanidou M; Malisiovas N
    Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007-2015.
    Tsai CS; Hung YP; Lee JC; Lee NY; Chen PL; Syue LS; Li MC; Li CW; Ko WC
    J Microbiol Immunol Infect; 2018 Apr; 51(2):243-250. PubMed ID: 28089100
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gastric acid suppression and Clostridium difficile infection: is there a causal connection?
    Khanna S; Pardi DS
    Clin Gastroenterol Hepatol; 2012 May; 10(5):564; author reply 564. PubMed ID: 22289872
    [No Abstract]   [Full Text] [Related]  

  • 80. Clostridium Difficile Infection in Rectal Cancer Patients after Diverted Loop Ileostomy Closure.
    Ghioldiş AC; Sârbu V; Pundiche M; Dan C; Butelchin C; Olteanu C; Popescu RC
    Chirurgia (Bucur); 2024 Feb; 119(1):36-43. PubMed ID: 38465714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.